1. Summary Information

 

 

Country

India

Company Name

SCHILLER HEALTHCARE INDIA PRIVATE LIMITED

Principal Name 1

Mr. Pravin Ratilal Gandhi

Status

Satisfactory

Principal Name 2

Mr. Vikram Dhirajlal Sanghvi

 

 

Registration #

11-111307

Street Address

111, Mahatma Gandhi Road, Fort, Mumbai–400001, Maharashtra, India

Established Date

15.10.1997

SIC Code

--

Telephone#

91-22-22674119

Business Style 1

Manufacturer

Fax #

91-22-22673898

Business Style 2

--

Homepage

http://www.schillerindia.com

Product Name 1

Cardiac

# of employees

100 (Approximately)

Product Name 2

Critical Care

Paid up capital

Rs. 42240900 /-

Product Name 3

Spirometry Systems

Shareholders

Foreign holdings- 49.50%

Directors or relatives of directors – 49.50%

Others 1%

Banking

HDFC Bank Limited

Public Limited Corp.

NO

Business Period

13 Years

IPO

NO

International Ins.

--

Public Enterprise

NO

Rating

Ba (45)

Related Company

Relation

Country

Company Name

CEO

Note

-

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2010

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

156,556,000

Current Liabilities

103,679,000

Inventories

119,581,000

Long-term Liabilities

107,678,000

Fixed Assets

22,466,000

Other Liabilities

--

Deferred Assets

205,000

Total Liabilities

 211,357,000

Invest& other Assets

44,000

Retained Earnings

45,254,000

 

 

Net Worth

87,495,000

Total Assets

298,852,000

Total Liab. & Equity

298,852,000

 Total Assets

(Previous Year)

291,321,000

 

 

P/L Statement as of

31.03.2010

(Unit: Indian Rs.)

Sales

459,094,000

Net Profit

11,256,000

Sales(Previous yr)

496,366,000

Net Profit(Prev.yr)

6,921,000

 

MIRA INFORM REPORT

 

 

Report Date :

16.03.2011

 

IDENTIFICATION DETAILS

 

Name :

SCHILLER HEALTHCARE INDIA PRIVATE LIMITED

 

 

Registered Office :

111, Mahatma Gandhi Road, Fort, Mumbai–400001, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

15.10.1997

 

 

Com. Reg. No.:

11-111307

 

 

CIN No.:

[Company Identification No.]

U33110MH1997PTC111307

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMS22847G

 

 

PAN No.:

[Permanent Account No.]

AADCS5091B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Cardiac, Critical Care and Spirometry Systems.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 350000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and a reputed company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually Correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office :

111, Mahatma Gandhi Road, Fort, Mumbai–400001, Maharashtra, India

Tel. No.:

91-22-22674119 / 28263520 / 0269 / 66920520

Fax No.:

91-22-22673898 / 25263525 /3258 / 28263525 / 28263520

E-Mail :

mail@schillerindia.com

schiller@vsnl.com

lquest@bom2.vsnl.net.in

Website :

http://www.schillerindia.com

 

 

Corporate Office :

D C Silk Mills Compound, A Wing, 1st Floor, 5, Chunawala Estate, Kondivita Lane, Andheri – Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra, India

Tel. No.:

91-22-61523333 / 28263520 / 56920520 / 39550953

Fax No.:

91-22-28263525

E-Mail :

sales@schillerindia.com

 

 

Factory 1 :

408/5-2, Ground Floor, 7th Main, 2nd Block, Jayanagar, Bangalore – 560011

Tel. No.:

91-80-26564045 / 4959 / 3092344

Fax No.:

91-80-26564045

E-Mail :

seshadri@schillerindia.com

 

 

Factory 2 :

No. 17, Pondy Villupuram Road, Balaji Nagar, Oulgaret, Pondicherry - 605 010, Tamilnadu, India

Tel No.:

91-413-278160 /279240 / 2291160 / 2949 / 309 8599

Mobile No.:

91- 9366192052

Fax No.:

91-413-279240 / 0413-2291240

Email :

schpon@satyam.net.in

hmohan@schillerindia.com

 

 

Branches :

Located At :

  • Ahmedabad
  • Bangalore
  • Kolkata
  • Chennai
  • Cochin
  • Hyderabad
  • New Delhi
  • Pondicherry
  • Pune

 

 

DIRECTORS

 

As On : 21.07.2010

 

Name :

Mr. Pravin Ratilal Gandhi

Designation :

Director

Address :

19 Fulchand Nivas, 5th Floor, Chowpatty Sea Face, Mumbai – 400007, Maharashtra,  India

Date of Birth/Age :

29.06.1944

Date of Appointment :

15.10.1997

 

 

Name :

Mr. Vikram Dhirajlal Sanghvi

Designation :

Director

Address :

Flat No. 6, Shangri la, 27-A, Carmichael Road, Mumbai – 400026, Maharashtra,  India

Date of Birth/Age :

26.08.1959

Date of Appointment :

01.04.2009

 

 

Name :

Mr. Doppler George Domnik

Designation :

Director

Address :

Brueoelstrasse 66, CH -6415, Arth, Switzerland

Date of Birth/Age :

16.10.1968

Date of Appointment :

29.05.2001

 

 

Name :

Mr. Eugen Alfred Schiller

Designation :

Director

Address :

Plot No. 112, Sion-Koliwada Road, Sion (East), Mumbai-4000022, Maharashtra,  India

Date of Birth/Age :

08.04.1943

Date of Appointment :

26.04.1998

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As On : 21.07.2010

 

Names of Shareholders

 

No. of Shares

Vikram Dhirajlal Sanghvi

 

1690

Schiller AG.

 

209088

Pravin R. Gandhi,

 

4224

Nandita P. Gandhi

 

3380

Radhika P. Gandhi

 

13933

Kunal P. Gandhi

 

17989

Sarla D. Sanghvi

 

5733

Pravin R. Gandhi

 

16972

Amla D. Sanghvi

 

1

Neeta V. Sanghvi

 

2

Aditi V. Sanghvi

 

1

Neha V. Sanghvi

 

1

Nayana T. Currim bhoy

 

2

Vikram D. Sanghvi

 

44838

Yashraj Sanghvi

 

39624

Neha Sanghvi

 

1

Anuradha Sanghvi

 

338

Priya Sanghvi

 

203

Nirupama Sanghvi

 

338

Vikram Sanghvi

 

2

Amla Sanghvi

 

2

Jayshree K Gandhi

 

43125

Bansri M Bux

 

2200

Janaki V Patel

 

6948

Priya J Madhavdas

 

135

Yashraj G Sanghvi

 

11635

Vikram Sanghvi

 

4

 

 

 

Total

 

422409

 

As On : 21.07.2010

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

49.50

Directors or relatives of directors

 

49.50

Other

 

1.00

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Cardiac, Critical Care and Spirometry Systems.

 

 

Products :

Item Code No.

Product Description

9018

Medical Equipments

 

  • Truscope II
  • Truscope mini
  • Oxywave
  • Cardioplus
  • Defigard 400
  • Mistral MV 2000
  • Sophie
  • Christina
  • F120
  • Uni-Vent Eagle 754
  • Uni-Vent 73x
  • Evadrop Dual
  • Evadrop Stack
  • Evadrop SP 300
  • Defigard 4000
  • Defigard 5000
  • Fred Easy
  • Fred Easyport
  • Cardiovit at 101 Tele
  • Cardiovit CS-200 Excellence
  • Cardiovit CS-20
  • Microvit MT-101 Nano
  • BR-102 plus
  • Spirovit SP-1
  • PC spirometry
  • Cardiovit CS-200 Ergo - Spiro
  • Truscope Classic
  • Meditom DT-400p / 300p
  • Argus AFM
  • Fetus BFM 900
  • Maglife Serenity
  • Maglife Light
  • Argus Capnox
  • Argus Capno
  • Argus Multigas
  • Emma
  • Truscope II Multigas
  • Evadrop MP-1000
  • Samvid
  • Pc Spirometry
  • Medilog Darwin
  • Medilog AR12
  • Medilog FD12

 

 

Agencies Held :

  • Schiller AG, Switzerland
  • Welch-Allyn Inc, USA
  • Medrad Inc, USA
  • Sunlight, Israel

 

 

GENERAL INFORMATION

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

  • HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400013, Maharashtra, India

 

  • Bank of India, Mumbai Main Branch, Advances Department, 70/80 M G Road, Ground Floor, Fort, Mumbai – 400001, Maharashtra, India

 

 

Facilities :

Particulars

As on 31.03.2010 (Rs. In Millions)

As on 31.03.2009 (Rs. In Millions)

Secured Loan

 

 

From Banks

 

 

Cash Credit

 

 

Bank of India

(Secured against Hypothecation of inventories, book debts and collateral security against movable fixed assets and personally guaranteed by some directors and their relatives.)

0.099

29.215

HDFC Bank

(Secured against Hypothecation of inventories, book debts and collateral security against movable fixed assets and personally guaranteed by some directors )

2.578

--

Working Capital Demand Loan

(amount payable within 1 year)

 

 

Bank of India

(Secured against Hypothecation of inventories, book debts and collateral security against movable fixed assets and personally guaranteed by some directors and their relatives)

45.000

--

HDFC Bank

(Secured against Hypothecation of inventories, book debts and collateral security against movable fixed assets and personally guaranteed by some directors.)

25.000

37.500

Total

72.677

66.715

 

 

 

Particulars

As on 31.03.2010 (Rs. In Millions)

As on 31.03.2009 (Rs. In Millions)

From a shareholders

35.000

42.500

 

 

 

Total

35.000

42.500

 

 

 

Banking Relations :

Good

 

 

Auditors :

 

Name :

Mayur Kapadia

Chartered Accountant

Address :

C/o, M.G. Ved and Company, 6th Floor, Palekar Chambers, Opposite Metro Adlabs, Mumbai–400002, Maharashtra, India

Tel. No.:

91-22-65062794

E-Mail :

mgv01@hothway.com

 

 

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

425000

Equity Share

Rs.100/- Each

Rs. 42.500 Millions

 

 

 

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

422409

Equity Share

Rs.100/- Each

Rs. 42.241 Millions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FINANCIAL DATA

[All figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

42.241

42.241

42.241

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

45.254

34.492

28.065

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

87.495

76.733

70.306

LOAN FUNDS

 

 

 

1] Secured Loans

72.678

66.715

84.303

2] Unsecured Loans

35.000

42.500

23.075

TOTAL BORROWING

107.678

109.215

107.378

DEFERRED TAX LIABILITIES

0.000

0.102

0.691

 

 

 

 

TOTAL

195.173

186.050

178.375

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

22.466

21.817

23.336

Capital work-in-progress

0.044

0.825

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.205

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

119.581
97.950

107.856

 

Sundry Debtors

132.726
142.618

134.333

 

Cash & Bank Balances

4.496
9.548

12.545

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

19.334
18.563

20.546

Total Current Assets

276.137
268.679

275.280

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Current Liabilities

90.079
91.847

106.983

 

Provisions

13.600
13.424

13.258

Total Current Liabilities

103.679
105.271

120.241

Net Current Assets

172.458
163.408

155.039

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

195.173

186.050

178.375

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

459.094

496.366

375.715

 

 

Other Income

5.756

2.419

2.380

 

 

TOTAL                                     (A)

464.850

498.785

378.095

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Goods Sold

300.617

317.031

230.757

 

 

Manpower Cost

51.173

51.417

35.301

 

 

Established and Other Expenses

24.560

30.793

17.255

 

 

Sales and Marketing Expenses

36.390

52.366

41.843

 

 

Rates and Taxes

13.786

13.497

12.202

 

 

Donation

1.000

0.500

2.000

 

 

TOTAL                                     (B)

427.526

465.604

339.358

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

37.324

33.181

38.737

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

14.495

15.693

14.536

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

22.829

17.488

24.201

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

5.098

4.509

2.319

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

17.731

12.979

21.882

 

 

 

 

 

Less

TAX                                                                  (I)

6.475

6.058

8.609

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

11.256

6.921

13.273

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

34.127

27.700

14.921

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

44.889

34.127

27.700

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

6.713

21.596

25.141

 

 

Commission Earnings

6.124

6.011

3.416

 

TOTAL EARNINGS

12.837

27.607

28.557

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

20.574

17.540

 

 

Stores & Spares

NA

253.920

201.147

 

 

Capital Goods

NA

0.309

0.561

 

TOTAL IMPORTS

NA

274.803

219.248

 

 

 

 

 

 

Earnings Per Share (Rs.)

--

16.39

43.46

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

2.42

1.38

3.51

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

3.86

2.63

5.82

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.93

4.49

7.33

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.20

0.17

0.31

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.41

2.80

3.24

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.66

2.55

2.29

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Operations

 

In difficult economic and business scenario worldwide Board of Directors are very happy to announce that the company has been able to hold on to the top line. In this year the company had taken decision to discontinue its strategic partnership with Medard Inc U.S.A. due to continuously lower margins. In nutshell, both these factors have resulted in the top line remaining almost stagnant. Total Income being at Rs. 464.900 millions as compared to Rs. 498.800 millions of previous year

 

However as a result of stringent cost management and favorable foreign exchange rates, the  company has been able to improve upon its margins. The PBDlT Profit of your company has increased from Rs. 33.200 millions to Rs. 37.300 millions which has increased income from 6.68% of Sales to 8.12% of Sales 

 

The PBT of the company has also shown improvement by growing from 13.000 millions to Rs. 17.700 millions thereby showing growth of 37% over previous year. Profit before tax to sales margin has also improved from 2.61 % and 3.86%

 

There has been major changes in the composition of business of the company during the year. The company's efforts in concentrating on Government and Turnkey Business have paid rich dividend by improving profitability as well as negating the effects of lower private business during recession time. The directors are happy to inform that the company has very healthy Order-Book position at the end of the year which shows promising year ahead. During the year, new service centre got operational at Puducherry. The company has also launched additional products during the year like Single Channel ECG Machine and has substantially increased its Ventilator business.

 

FUTURE OUTLOOK

 

The company has charted out Business plan for substantial expansion of its business. Company is exploring possibility to venture out in the field of

 

a) Mobile Healthcare

b) Turnkey solutions

c) Medical IT

d) Other segment of critical care like OT Lights, Tables etc.

 

During the year after Balance Sheet date, company has already tied up with Tyco Healthcare far providing customer support services to their customers of Imaging products. Company is also in talk with other equipment  manufacturers far OEM branding of their equipments in critical care segment, like Ventilators, OT Lights, Tables etc.

 

Form : 8

 

Bankers Charges Report as per Registry

 

Name of the company

SCHILLER HEALTHCARE INDIA PRIVATE LIMITED

Presented By

Mr. Vikram D. Sanghvi, Director

1) Date and description of instrument creating the change

Letter of Hypothecation of Stocks and Book debts dated 28th October, 2004

2) Amount secured by the charge/amount owing on the securities of charge

Re.10.000 Millions by way of cash credit facility.

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Hypothecation of all stock in trade present and future consisting of raw materials, finished goods, goods in process and trading goods and other merchandise whatsoever belonging to the company wherever situate and hypothecation of all the book debts, outstanding, receivable, claims and bills which are now due and owing or which may at any time hereafter during the continuation of this security becomes due and owing to the company in the course of it business by any person firm, company or body corporate or by government municipal local or public or semi government body or authority or any body corporate or undertaking or project in public sector.

4) Gist of the terms and conditions and extent and operation of the charge.

The Bank has sanctioned cash credit facilities to the extent of Rs.10.000 Millions at the interest rate of 10.75%+Interest tax as applicable on monthly rests. The interest rate may be varied by the bank at any time.

 

The facilities are repayable on demand.

5) Name and Address and description of the person entitled to the charge.

HDFC Bank Limited

HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400013, Maharashtra, India

6) Date  and brief description of instrument modifying the charge

Not Applicable

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Not Applicable

 

Corporate identity number of the company

U33110MH1997PTC111307

Name of the company

SCHILLER HEALTHCARE INDIA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

111 Mahatma Gandhi Road Fort, Mumbai – 400001, Maharashtra, India

This form is for

Modification of charge

Type of charge

Book debts

Movable property (not being pledge)

Particular of charge holder

Bank of India, Mumbai Main Branch, BOI Building,Gr. Floor , 70/80 M G Road , Fort, Mumbai – 400001, Maharashtra, India

Nature of instrument creating charge

Supplemental deed of Hypothecation.

Date of instrument Creating the charge

19/01/2011

Amount secured by the charge

Rs. 130.000 millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest :

Interest/Commission as per Schedule III of Supplemental deed attached or at such other rate/s of interest as may be notified by the bank from time to time.

 

Terms of repayment :

On Demand.

 

Margin :

25 % against RM /FG; 40% against book debts(upto 120 days) ;10% for Packing Credit, FBP/FBN(DP/DA 90days) and LC I/F DP/DA 180 days; 15% for Guarantee I/F or as specified by Bank from time to time.

 

Extent and operation of the charge :

Security in favour of Bank not only for the payments of the amounts due under or in respect of or in connection with or in any wise concerning  with the said facilities for principal with interest/commission, costs, charges and exps. and other monies under the principal and modified deeds of hypothecation but also for the payments due under or in respect of or in connection with or in any wise concerning the said facilities as enhanced & under the addtl./revised facilities granted.

 

Other :

by the bank to the borrower.

Revised Facilities and Limits (Rs. in millions):(A) Borrowal Limits: i) CC (Hyp. of Stock)Rs.800,ii) CC (Hyp. of book debts) Rs.800, iii) WCDL Rs.480 Max.(i + ii + iii) Rs.800 iv)Packing Credit Rs.25 v)FBP/FBN (DP/DA 90 days) Rs.25 Total WCFB Rs.800 (B) Non Borrowal Limits: i)L/C (I/F) DP/DA 180 days Rs.500, ii) Guarantee I/F Rs.500 Total Rs.500 Aggregate (A+B) Rs.1300.

Short particulars of the property charged (Including location of the property)

  1. a) All tangible movable machineries and plant both present and future at Pondichery, Banglore, Mumbai etc. or wherever else b) All tangible movable properties and assets
  2. of whatsoever nature (both present and future) c) All present and future book debts, outstanding, money receivables, claims, bills which are now due and owing or which may any time hereafter
  3. During the continuance of this security become due and owing to the Borrower. Details as Supplemental deed attached.

Date of instrument modifying the charge

09/11/2009

Particulars of the present modification

12th Modification. The principal amount of charge on the Hypothecated assets is increased from Rs.105.000 millions   to Rs.130.000 millions. Revised Facilities and Limits- (Rs.in millions):(A) Borrowal Limits: i) CC (Hyp. of Stock) Rs.800,ii) CC (Hyp.of book debts) Rs.800, iii) WCDL Rs.480 Max.(i + ii + iii) Rs.800 iv)Packing Credit Rs.25 v)FBP/FBN (DP/DA 90 days) Rs.25 Total WCFB Rs.800 (B) Non Borrowal Limits: i)L/C (I/F) DP/DA 180 days Rs.500, ii) Guarantee I/F Rs.500 Total (i + ii) Rs.500 Aggregate (A+B) Rs.1300.

 

As per Web Details

 

Profile

 

Subject is a joint-venture between Schiller AG of Switzerland, a world leader in Medical Diagnostic Solutions, with presence in over 100 countries and RR Group, India. The company was set-up in 1997 with an idea to make quality products available to the Indian medical market. Currently their product range includes multichannel ECG machines, monitoring systems, defibrillators, stress test systems, ventilators, pressure injectors, infusion pumps, surgical diathermy, holter systems, spirometry systems, pulse oximeters, and telemedicine among others Schiller India is one of the fastest growing medical equipment company in India. The company's mission is to constantly provide international quality products and solutions at affordable prices.

In addition to marketing and supporting products from Schiller AG, Schiller India has a state of the art manufacturing facility at Puducherry where they manufacture a range of medical diagnostic equipment which are complementary to Schiller AG's products both in functionality and pricing. The company has a stong R and D team which develops at least two to three products every year which are commercially viable.

Subject is also a distributor of products of other companies. They have tie-ups with Stephan Gmbh of Germany for ventilators and Impact USA for transport ventilators. Their OEM tie-ups include Daiwha, Korea, MEK, Korea and Phasein of Sweden. They have a diversified product offering in the medical equipment market.

Subject is currently the market leader in multi-channel ECG machines. They are a leading player in the defibrillator and stress test market. In recent years they have dramatically increased their market share in the Monitoring segment. In pressure injectors too, they have a substantial share of the market. A combination of high quality products and ability to successfully market them has helped us in substantially cornering a higher pie of the medical equipment market. They currently have over 20,000 installations across India, Nepal , Bangladesh and Sri-Lanka.

The company has Offices in 35 locations around the country and a large team of engineers both for sales and service support. Realising that the potential growth areas are the smaller cities, Schiller India has widened its dealer network to include them. Currently they have a strong network of over 70 sales and service dealers spread across the country. A strong after sales support to their valuable customer base has been Schiller India's core competency.


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 45.27

UK Pound

1

Rs. 72.94

Euro

1

Rs. 63.08

 

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.